semaglutide weight loss stall : r/Semaglutide weight plateau on semaglutide 7

The drug is currently in Phase 2 of development and is being developed by Bird Rock Bio Sub, Inc.

Semaglutide should not be used with another semaglutide-containing product or another GLP-1 agonist

Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans

The dose can be increased gradually every 4 weeks up to a maximum of 2.4 mg weekly after the fifth month

EGR-1 is a gene that is considered to respond immediately and is potentially involved in the generation of cytokines and growth factors, as well as the early formation of extracellular matrix components like collagen